Apremilast Does Not Cause Clinically Significant Liver Problems or Right-Sided Back Pain
Apremilast (Otezla) is not associated with hepatotoxicity and does not require routine liver monitoring—your right-sided back pain is unlikely to be related to this medication. 1
Key Safety Profile Evidence
The 2020 Joint AAD-NPF Guidelines explicitly state that apremilast has "a positive safety feature" and can be used in patients with complex medical issues where other systemic agents are contraindicated 1. Critically, the guidelines note that "routine laboratory screening and monitoring can be considered on an individual basis" but is not required—a stark contrast to medications with hepatotoxic potential 1.
What the FDA Label Says
The FDA label for Otezla confirms that apremilast pharmacokinetics are not affected by moderate or severe hepatic impairment, and no dosage adjustment is necessary 2. This indicates the drug does not accumulate in or damage the liver.
Long-Term Safety Data
A comprehensive 5-year pooled analysis of 4,183 patients (6,788 patient-years of exposure) found no hepatotoxicity signals and confirmed that most adverse events were mild to moderate 3. The most common side effects remain gastrointestinal (diarrhea, nausea), headache, and upper respiratory infections—not liver-related symptoms 1.
Why Your Pain Is Unlikely Related to Apremilast
Right upper quadrant or right-sided back pain is not listed among apremilast's adverse effects in any guideline or FDA documentation. The evidence shows:
- No elevation in liver enzymes (ALT, AST) in clinical trials 1
- No requirement for hepatic monitoring unlike methotrexate or other hepatotoxic agents 1
- Emerging evidence suggests apremilast may actually be hepatoprotective, reducing hepatic steatosis and improving liver function markers in metabolic dysfunction-associated liver disease 4, 5
What to Consider Instead
If you're experiencing right-sided back pain while on apremilast, investigate alternative causes:
- Musculoskeletal issues (most common cause of back pain)
- Kidney problems (apremilast is renally cleared, but doesn't cause kidney damage)
- Gallbladder disease (right upper quadrant pain)
- Underlying psoriatic arthritis (if you have this condition)
- Unrelated medical conditions
Important Caveats
While apremilast doesn't cause liver problems, be aware of its actual side effects:
- Gastrointestinal symptoms occur in 70-80% of patients within the first 2 weeks but are typically mild and resolve within a month 1
- Weight loss (5-10% decrease) occurs in 12% of patients—monitor weight and consider discontinuation if >5% loss 1
- Depression reported in ~1% of patients—discuss any psychiatric history before starting 1
- Dehydration risk in elderly patients from GI effects 1
Bottom line: Apremilast is metabolized in the liver via CYP450 but does not cause hepatotoxicity 1. Your right-sided pain warrants evaluation for other causes, not discontinuation of apremilast based on liver concerns.